Ask The Board
-
What Tips Would You Give To An Early-Stage Biopharma CEO Preparing To Present New Clinical Data At A Medical Meeting?
2/1/2023
See the answer from Rich Daly, president at CARsgen Therapeutics.
-
Do You Think That Biopharmaceutical Companies Receiving An FDA Accelerated Approval Should Be Required To Enroll Patients In A Confirmatory Study Prior To Launch?
2/1/2023
See the answer from Mary Rose Keller, VP of clinical operations at Acrivon Therapeutics.
-
What Key Characteristics Or Attributes — Beyond Functional Or Scientific Expertise — Should A CEO Look For In Considering The Addition Of A New Board Member?
1/3/2023
See the answer from Thomas Wiggans, chairman and CEO of Pardes Biosciences.
-
What Advice Would You Give To Small Biotechs That Have Delayed Or Canceled Plans For A Public Offering, But Still Need Funding To Advance Clinical Programs?
1/3/2023
See the answer from Pamela Reilly Contag Ph.D., CEO and President at BioEclipse Therapeutics.
-
What Impact Do You Think The Inflation Reduction Act Will Have On The Biopharma Industry Over The Next Five Years?
12/1/2022
See the answer from Ron Cohen, president and CEO at Acorda Therapeutics.
-
What Factors Are Most Important To Consider When Collaborating Externally On A Combination Drug Clinical Trial?
12/1/2022
See the answer from Martin Lehr, CEO at Context Therapeutics.
-
What Do Corporate Diversity, Equity, And Inclusion (DE&I) Programs Most Often Get Wrong? How Could They Be Improved?
11/1/2022
See the answer from Paul Hastings, president and CEO of Nkarta Therapeutics and chair of the board of directors at BIO.
-
How Can Leaders Keep Employees Motivated And Focused On Long-Term Objectives In The Context Of Difficult Market Conditions And Short-Term Belt Tightening?
11/1/2022
See the answer from Paula Ragan, cofounder, president, and CEO of X4 Pharmaceuticals.
-
How Can Novel Data Registries Inform The Development Of New Medicines, Or Improve Patient Care?
10/3/2022
See the answer from Lisa Conte, founder, president, and CEO of Jaguar Health.
-
Your New Book Is Pharma And Profits: Balancing Innovation, Medicine And Drug Pricing. What Is Most Often Overlooked In Political Discussions About Drug Prices?
10/3/2022
See the answer from John Lamattina, a senior partner at PureTech Health.